Metabolic alterations and hepatitis C: From bench to bedside

In addition to causing cirrhosis and hepatocellular carcinoma, hepatitis C virus (HCV) is thought to cause hypolipidemia, hepatic steatosis, insulin resistance, metabolic syndrome, and diabetes. The viral life cycle of HCV depends on cholesterol metabolism in host cells. HCV core protein and nonstru...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of gastroenterology : WJG 2016-01, Vol.22 (4), p.1461-1476
1. Verfasser:	Chang, Ming-Ling
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antiviral Agents - therapeutic use Cardiovascular Diseases - metabolism Cardiovascular Diseases - virology Diabetes Mellitus - metabolism Diabetes Mellitus - virology Dyslipidemias - metabolism Dyslipidemias - virology Energy Metabolism - drug effects Fatty Liver - metabolism Fatty Liver - virology Genome, Viral Genotype Glucose - metabolism Hepacivirus - drug effects Hepacivirus - genetics Hepacivirus - metabolism Hepacivirus - pathogenicity Hepatitis C - complications Hepatitis C - drug therapy Hepatitis C - metabolism Hepatitis C - virology Host-Pathogen Interactions Humans Lipid Metabolism Liver - drug effects Liver - metabolism Liver - virology Metabolic Syndrome - metabolism Metabolic Syndrome - virology Risk Factors Signal Transduction Topic Highlight
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!